Navigation Links
Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
Date:6/5/2013

(PRWEB) June 05, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, is hosting a complimentary, half-day seminar on “Product Enhancement through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management” on June 18, 2013 at the MassBio Headquarters in Cambridge, Massachusetts.

Complex dosage forms provide novel business opportunities for companies to leverage their existing products and intellectual property. Pharmaceutical industry experts will discuss several life cycle management strategies to enhance the product life cycle and extend the life of a drug.

Topics covered, but not limited to, include:

  • How to enhance existing product portfolio
  • How to improve and register existing marketed products
  • How to get a product to the market, including regulatory filing and approval requirements for complex dosage forms
  • Challenges for a sterile solution that requires lyophilization in order to meet commercial stability requirements
  • Drug formulation considerations in order to get a lyophilized product commercialized

Presentations will be provided by Patheon employees, Anil Kane, Ph.D., MBA, Executive Director, Global PDS Formulation Sciences, and Don Barbieri, Associate Director of Formulation and Process Development, as well as by Doug Stockdale, MBA, Life Sciences Executive, and John McCarty, Consultant with Pharmaceutical Productions.    

Visit the company’s website at http://www.patheon.com/Knowledge-Library/Events.aspx to learn more or register for the upcoming seminar. Seating is limited.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 17 locations, including 13 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10789471.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Louis Amendolagine and Dr. Geri Friefeld Launch a Ground Breaking Cavity Prevention Program That Lowers Decay Rates by 74%
2. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
3. Health Diagnostic Laboratory, Inc.s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
4. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
5. Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
6. Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It
7. Probiotic Action The “Best Acne Treatment” Shares New Insight on the Future of Preventing the Spread of Acne Causing Germs
8. A Media Event on Clinical Developments in Gene and Cell Therapy
9. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
10. Marshfield Dentist Launches Groundbreaking Cavity Prevention Program That Can Lower Tooth Decay Rates by 74 Percent
11. Dentistry at Somerset Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... PHILADELPHIA , June 28, 2017 ... Pediatrics at Georgetown University School of Medicine, and Founder, ... author of a study that has helped clarify the ... disease (PD) and other neurodegenerative diseases. Denise Barbut ... of Enterin Inc. was senior co-author of the study. ...
(Date:6/28/2017)... St. Louis, MO (PRWEB) , ... June 28, 2017 , ... ... to a panel of leading experts gathered at the Society of Nuclear Medicine and ... the parent isotope of technetium-99m (Tc-99m), which is used in 30 to 40 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... According to ... carbon (PAC)-based materials do not have negative short- or long-term effects on benthic ... with polychlorinated biphenyls (PCBs) located at the Puget Sound Naval Shipyard & Intermediate ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Workgroup for Electronic Data ... to create efficiencies in healthcare information exchange and a statutory advisor to the U.S. ... of the federal Office of the National Coordinator for Health Information Technology, will deliver ...
Breaking Biology Technology:
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
Breaking Biology News(10 mins):